000			02065cam a2200409 i 4500
999			_c10394 _d10394
001			17921915
005			20190506094005.0
008			131029t20142014ne a b 001 0 eng
010			_a 2013043146
020			_a9780123820303 (alk. paper)
020			_a0123820308 (alk. paper)
040			_aDLC _beng _cDLC _erda _dDLC
042			_apcc
050	0	0	_aRS403 _b.S55 2014
082	0	0	_a615.19 _223 _bS.R.O
100	1		_aSilverman, Richard B., _eauthor. _91658
245	1	4	_aThe organic chemistry of drug design and drug action.
250			_aThird edition / _bRichard B. Silverman, Northwestern University, Department of Chemistry, Department of Molecular Biosciences, Chemistry of Life Processes Institute, Center for Molecular Innovation and Drug Discovery, Evanston, Illinois, USA, Mark W. Holladay, Ambit Biosciences Corporation, Departments of Drug Discovery and Medicinal Chemistry, San Diego, California, USA.
264		1	_aAmsterdam ; _aBoston : _bElsevier/AP, Academic Press, is an imprint of Elsevier, _c[2014]
264		4	_c©2014
300			_axviii, 517 pages : _billustrations (some color) ; _c29 cm
336			_atext _2rdacontent
337			_aunmediated _2rdamedia
338			_avolume _2rdacarrier
500			_apharmacy bookfair2016
504			_aIncludes bibliographical references and index.
505	0		_aIntroduction -- Lead discovery and lead modification -- Receptors -- Enzymes -- Enzyme inhibition and inactivation -- Dna-interactive agents -- Drug resistance and drug synergism -- Drug metabolism -- Prodrugs and drug delivery systems.
650		0	_aPharmaceutical chemistry.
650		0	_aBioorganic chemistry. _91660
650		0	_aMolecular pharmacology. _91661
650		0	_aDrugs _xDesign.
700	1		_aHolladay, Mark W., _eauthor.
856			_3Abstract _uhttp://repository.fue.edu.eg/xmlui/handle/123456789/1812
906			_a7 _bcbc _corignew _d1 _eecip _f20 _gy-gencatlg
942			_2ddc _cTB